RPRD1B and hepatocellular carcinoma: CREPT knockdown in hepatocellular carcinoma (HCC) leads to the diminished expression of NF-kB/NRF2 target genes, such as Sod2 and Fth1, contributing to the release of reactive oxygen species (ROS) accumulation and impaired liver function [23].